Back to Search Start Over

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

Authors :
Im, Kate M.
Kirchhoff, Tomas
Wang, Xianshu
Green, Todd
Chow, Clement Y.
Vijai, Joseph
Korn, Joshua
Gaudet, Mia M.
Fredericksen, Zachary
Pankratz, V. Shane
Guiducci, Candace
Crenshaw, Andrew
McGuffog, Lesley
Kartsonaki, Christiana
Morrison, Jonathan
Healey, Sue
Sinilnikova, Olga M.
Mai, Phuong L.
Greene, Mark H.
Piedmonte, Marion
Rubinstein, Wendy S.
Hogervorst, Frans B. L.
Rookus, Matti A.
Collee, Margriet J.
Hoogerbrugge, Nicoline
van Asperen, Christi J.
Meijers-Heijboer, Hanne E. J.
van Roozendaal, Cees E.
Caldes, Trinidad
Perez Segura, Pedro
Jakubowska, Anna
Lubinski, Jan
Huzarski, Tomasz
Blecharz, Pawel
Nevanlinna, Heli
Aittomaki, Kristiina
Lazaro, Conxi
Blanco, Ignacio
Barkardottir, Rosa B.
Montagna, Marco
D'Andrea, Emma
Devilee, Peter
Olopade, Olufunmilayo I.
Neuhausen, Susan L.
Peissel, Bernard
Bonanni, Bernardo
Peterlongo, Paolo
Singer, Christian F.
Rennert, Gad
Lejbkowicz, Flavio
Andrulis, Irene L.
Glendon, Gord
Ozcelik, Hilmi
Toland, Amanda Ewart
Caligo, Maria Adelaide
Beattie, Mary S.
Chan, Salina B.
Domchek, Susan M.
Nathanson, Katherine L.
Rebbeck, Timothy R.
Phelan, Catherine M.
Narod, Steven A.
John, Esther M.
Hopper, John L.
Buys, Saundra
Daly, Mary B.
Southey, Melissa C.
Terry, Mary Beth
Tung, Nadine
Hansen, Thomas V. O.
Osorio, Ana
Benitez, Javier
Duran, Mercedes
Weitzel, Jeffrey N.
Garber, Judy
Hamann, Ute
Peock, Susan
Cook, Margaret
Oliver, Clare T.
Frost, Debra
Platte, Radka
Evans, D. Gareth
Eeles, Ros
Izatt, Louise
Paterson, Joan
Brewer, Carole
Hodgson, Shirley V.
Morrison, Patrick J.
Porteous, Mary E.
Walker, Lisa
Rogers, Mark T.
Side, Lucy E.
Godwin, Andrew K.
Schmutzler, Rita K.
Wappenschmidt, Barbara
Laitman, Yael
Meindl, Alfons
Deissler, Helmut
Varon-Mateeva, Raymonda
Preisler-Adams, Sabine
Kast, Karin
Venat-Bouvet, Laurence
Stoppa-Lyonnet, Dominique
Chenevix-Trench, Georgia
Easton, Douglas F.
Klein, Robert J.
Daly, Mark J.
Friedman, Eitan
Dean, Michael
Clark, Andrew G.
Altshuler, David M.
Antoniou, Antonis C.
Couch, Fergus J.
Offit, Kenneth
Gomez Garcia, Encarna
Blok, Marinus
Gold, Bert
center for cancer research
Cancer inflammation
Department of Environmental Medicine
New York University School of Medicine-NYU Cancer Institute
Department of Laboratory Medicine and Pathology
Mayo Clinic
Department of Genetics [Boston]
Harvard Medical School [Boston] ( HMS )
Cornell University
Department of Medical Genetics
Centre for Cancer Genetic Epidemiology
University of Cambridge [UK] ( CAM )
Queensland Institute of Medical Research
Centre de Recherche en Cancérologie de Lyon ( CRCL )
Université Claude Bernard Lyon 1 ( UCBL )
Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS )
Centre Léon Bérard [Lyon]
Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics
National Institutes of Health ( NIH ) -National Cancer Institute ( NIH )
Statistical and Data Center
Roswell Park Cancer Institute [Buffalo]
Department of Clinical Genetics
Erasmus University Medical Center-Family Cancer Clinic
Human Genetics
Molecular Oncology Laboratory
Hospital Clínico San Carlos
Department of Genetics and Pathology
Pomeranian Medical University-International Hereditary Cancer Centre
International Hereditary Cancer Center, Pomeranian Medical University
Department of Obstetrics and Gynecology
Helsinki University Central Hospital
Molecular Diagnostic Unit
IDIBELL-Catalan Institute of Oncology
Genetic Counselling Unit
Immunology and Molecular Oncology Unit
Istituto Oncologico Veneto IOV - IRCCS
Department of Oncology and Surgical Sciences
University of Padua and Istituto Oncologico Veneto IOV - IRCCS
Department of Genetic Epidemiology
Leiden University Medical Center (LUMC)
Unit of Medical Genetics
Fondazione IRCCS Istituto Nazionale Tumouri (INT)
Division of Cancer Prevention and Genetics
Unit of Molecular Bases of Genetic Risk and Genetic Testing
Fondazione IRCCS Istituto Nazionale Tumouri (INT)-Fondazione Istituto FIRC di Oncologia Molecolare
Department of Community Medicine and Epidemiology
CHS National Cancer Control Center
Ontario Cancer Genetics Network
Cancer Care Ontario
Departments of Molecular Genetics and Laboratory Medicine and Pathobiology
University of Toronto-Cancer Care Ontario
Samuel Lunenfeld Research Institute
Mount Sinai Hospital ( MSH )
Section of Genetic Oncology
University Hospital and University of Pisa
Depts of Medicine and Biostatistics and Epidemology
Abramson Family Cancer Research Institute-University of Pennsylvania School of Medicine
Women's College Research Institute
University of Toronto
Human Genetics Group
Spanish National Cancer Research Centre
Biomedical Research Centre Network for Rare Diseases
CIBER de Enfermedades Raras (CIBERER)
Institute of Biology and Molecular Genetics
Universidad de Valladolid [Valladolid] ( UVa )
Molecular Genetics of Breast Cancer
Deutsches Krebsforschungszentrum ( DKFZ )
Genetic Medicine
Manchester Academic Health Sciences Centre-Central Manchester University Hospitals
Oncogenetics Team
The Institute of Cancer Research and Royal Marsden NHS Foundation Trust
Clinical Genetics
Guy's and St. Thomas' NHS Foundation Trust
Addenbrookes Hospital
Royal Devon & Exeter Hospital
Medical Genetics Unit
University College of London [London] ( UCL )
South East of Scotland Regional Genetics Service
Western General Hospital
Oxford Regional Genetics Service
Churchill Hospital Oxford Centre for Haematology
Department of Gynaecology and Obstetrics
University Hospital of Cologne [Cologne]-Centre of Familial Breast and Ovarian Cancer-Centre for Integrated Oncology (CIO)
The Susanne Levy Gertner Oncogenetics Unit
Institute of Human Genetics
Technical University of Munich ( TUM )
University Hospital Ulm
Charite berlin
Westfälische Wilhelms-Universität Münster ( WWU )
University Hospital Carl Gustav Carus
Service d'Oncologie médicale [CHU Limoges]
CHU Limoges
Service de Génétique Oncologique
INSTITUT CURIE
Unité de génétique et biologie des cancers ( U830 )
Université Paris Descartes - Paris 5 ( UPD5 ) -Institut Curie-Institut National de la Santé et de la Recherche Médicale ( INSERM )
Cancer Research U.K. Genetic Epidemiology Unit
Strangeways Research Laboratory
Genetic Epidemiology Unit, Department of Public Health and Primary Care
Sackler Faculty of Medicine
Tel Aviv University [Tel Aviv]
Department of Molecular Biology and Genetics, Cornell University
Clinical Genetics Service
Memorial Sloane Kettering Cancer Center [New York]
New York University School of Medicine
NYU System (NYU)-NYU System (NYU)-NYU Cancer Institute
Harvard Medical School [Boston] (HMS)
Cornell University [New York]
University of Cambridge [UK] (CAM)
Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL)
Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)
National Institutes of Health [Bethesda] (NIH)-National Cancer Institute [Bethesda] (NCI-NIH)
National Institutes of Health [Bethesda] (NIH)
Erasmus University Medical Center [Rotterdam] (Erasmus MC)-Family Cancer Clinic
Universita degli Studi di Padova
Mount Sinai Hospital [Toronto, Canada] (MSH)
Abramson Family Cancer Research Institute-Perelman School of Medicine
University of Pennsylvania [Philadelphia]-University of Pennsylvania [Philadelphia]
Universidad de Valladolid [Valladolid] (UVa)
German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ)
University College of London [London] (UCL)
Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM)
Universitätsklinikum Ulm - University Hospital of Ulm
Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
Westfälische Wilhelms-Universität Münster (WWU)
Institut Curie [Paris]
Unité de génétique et biologie des cancers (U830)
Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)
Genetica & Celbiologie
RS: GROW - School for Oncology and Reproduction
Klinische Genetica
Universitat de Barcelona
Internal Medicine
Pediatric Surgery
Centre de Recherche en Cancérologie de Lyon (CRCL)
Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Mount Sinai Hospital (MSH)
Technical University of Munich (TUM)
Charité - Universitätsmedizin Berlin / Charite - University Medicine Berlin
Institut Curie
Université Paris Descartes - Paris 5 (UPD5)-Institut Curie-Institut National de la Santé et de la Recherche Médicale (INSERM)
Human genetics
CCA - Oncogenesis
Source :
Human Genetics, Human Genetics, Springer Verlag, 2011, 130 (5), pp.685-99. 〈10.1007/s00439-011-1003-z〉, Human Genetics, Springer Verlag, 2011, 130 (5), pp.685-99. ⟨10.1007/s00439-011-1003-z⟩, Human Genetics, 130(5), 685-699. Springer, Im, K M, Kirchhoff, T, Wang, X S, Green, T, Chow, C Y, Vijai, J, Korn, J, Gaudet, M M, Fredericksen, Z, Pankratz, V S, Guiducci, C, Crenshaw, A, McGuffog, L, Kartsonaki, C, Morrison, J, Healey, S, Sinilnikova, O M, Mai, P L, Greene, M H, Piedmonte, M, Rubinstein, W S, Hogervorst, FB, Rookus, M A, Collee, J M, Hoogerbrugge, N, van Asperen, C J, Meijers-Heijboer, E J, van Roozendaal, C E, Caldes, T, Perez-Segura, P, Jakubowska, A, Lubinski, J, Huzarski, T, Blecharz, P, Nevanlinna, H, Aittomaki, K, Lazaro, C, Blanco, I, Barkardottir, R B, Montagna, M, D'Andrea, E, Devilee, P, Olopade, O I, Neuhausen, S L, Peissel, B, Bonanni, B, Peterlongo, P, Singer, C F, Rennert, G, Lejbkowicz, F, Andrulis, I L, Glendon, G, Ozcelik, H, Toland, A E, Caligo, M A, Beattie, M S, Chan, S, Domchek, S M, Nathanson, K L, Rebbeck, T R, Phelan, C, Narod, S, John, E M, Hopper, J L, Buys, S S, Daly, M B, Southey, M C, Terry, M B, Tung, N, Hansen, T V O, Osorio, A, Benitez, J, Duran, M, Weitzel, J N, Garber, J, Hamann, U, Peock, S, Cook, M, Oliver, C T, Frost, D, Platte, R, Evans, D G, Eeles, R, Izatt, L, Paterson, J, Brewer, C, Hodgson, S, Morrison, P J, Porteous, M, Walker, L, Rogers, M T, Side, L E, Godwin, A K, Schmutzler, R K, Wappenschmidt, B, Laitman, Y, Meindl, A, Deissler, H & Varon-Mateeva, R 2011, ' Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers ', Human Genetics, vol. 130, no. 5, pp. 685-699 . https://doi.org/10.1007/s00439-011-1003-z, Human Genetics, 130, 685-99, Human genetics, 130(5), 685-699. Springer Verlag, Recercat. Dipósit de la Recerca de Catalunya, instname, Digital.CSIC. Repositorio Institucional del CSIC, Human Genetics, 130(5), 685-699. Springer-Verlag, Dipòsit Digital de la UB, Universidad de Barcelona, Human Genetics, 130(5), 685-699, Human Genetics, 130(5), 685-699. Springer Verlag, Human Genetics, 130, 5, pp. 685-99
Publication Year :
2011
Publisher :
HAL CCSD, 2011.

Abstract

Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ovarian cancer in Ashkenazi Jews (AJ). They are observed at increased frequency in the AJ compared to other BRCA mutations in Caucasian non-Jews (CNJ). Several authors have proposed that elevated allele frequencies in the surrounding genomic regions reflect adaptive or balancing selection. Such proposals predict long-range linkage disequilibrium (LD) resulting from a selective sweep, although genetic drift in a founder population may also act to create long-distance LD. To date, few studies have used the tools of statistical genomics to examine the likelihood of long-range LD at a deleterious locus in a population that faced a genetic bottleneck. We studied the genotypes of hundreds of women from a large international consortium of BRCA1 and BRCA2 mutation carriers and found that AJ women exhibited long-range haplotypes compared to CNJ women. More than 50% of the AJ chromosomes with the BRCA1 185delAG mutation share an identical 2.1 Mb haplotype and nearly 16% of AJ chromosomes carrying the BRCA2 6174delT mutation share a 1.4 Mb haplotype. Simulations based on the best inference of Ashkenazi population demography indicate that long-range haplotypes are expected in the context of a genome-wide survey. Our results are consistent with the hypothesis that a local bottleneck effect from population size constriction events could by chance have resulted in the large haplotype blocks observed at high frequency in the BRCA1 and BRCA2 regions of Ashkenazi Jews.

Details

Language :
English
ISSN :
03406717 and 14321203
Database :
OpenAIRE
Journal :
Human Genetics, Human Genetics, Springer Verlag, 2011, 130 (5), pp.685-99. 〈10.1007/s00439-011-1003-z〉, Human Genetics, Springer Verlag, 2011, 130 (5), pp.685-99. ⟨10.1007/s00439-011-1003-z⟩, Human Genetics, 130(5), 685-699. Springer, Im, K M, Kirchhoff, T, Wang, X S, Green, T, Chow, C Y, Vijai, J, Korn, J, Gaudet, M M, Fredericksen, Z, Pankratz, V S, Guiducci, C, Crenshaw, A, McGuffog, L, Kartsonaki, C, Morrison, J, Healey, S, Sinilnikova, O M, Mai, P L, Greene, M H, Piedmonte, M, Rubinstein, W S, Hogervorst, FB, Rookus, M A, Collee, J M, Hoogerbrugge, N, van Asperen, C J, Meijers-Heijboer, E J, van Roozendaal, C E, Caldes, T, Perez-Segura, P, Jakubowska, A, Lubinski, J, Huzarski, T, Blecharz, P, Nevanlinna, H, Aittomaki, K, Lazaro, C, Blanco, I, Barkardottir, R B, Montagna, M, D'Andrea, E, Devilee, P, Olopade, O I, Neuhausen, S L, Peissel, B, Bonanni, B, Peterlongo, P, Singer, C F, Rennert, G, Lejbkowicz, F, Andrulis, I L, Glendon, G, Ozcelik, H, Toland, A E, Caligo, M A, Beattie, M S, Chan, S, Domchek, S M, Nathanson, K L, Rebbeck, T R, Phelan, C, Narod, S, John, E M, Hopper, J L, Buys, S S, Daly, M B, Southey, M C, Terry, M B, Tung, N, Hansen, T V O, Osorio, A, Benitez, J, Duran, M, Weitzel, J N, Garber, J, Hamann, U, Peock, S, Cook, M, Oliver, C T, Frost, D, Platte, R, Evans, D G, Eeles, R, Izatt, L, Paterson, J, Brewer, C, Hodgson, S, Morrison, P J, Porteous, M, Walker, L, Rogers, M T, Side, L E, Godwin, A K, Schmutzler, R K, Wappenschmidt, B, Laitman, Y, Meindl, A, Deissler, H & Varon-Mateeva, R 2011, ' Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers ', Human Genetics, vol. 130, no. 5, pp. 685-699 . https://doi.org/10.1007/s00439-011-1003-z, Human Genetics, 130, 685-99, Human genetics, 130(5), 685-699. Springer Verlag, Recercat. Dipósit de la Recerca de Catalunya, instname, Digital.CSIC. Repositorio Institucional del CSIC, Human Genetics, 130(5), 685-699. Springer-Verlag, Dipòsit Digital de la UB, Universidad de Barcelona, Human Genetics, 130(5), 685-699, Human Genetics, 130(5), 685-699. Springer Verlag, Human Genetics, 130, 5, pp. 685-99
Accession number :
edsair.doi.dedup.....6b76209a3052a1556a0f6f989a4c88d4
Full Text :
https://doi.org/10.1007/s00439-011-1003-z〉